The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
After finishing at $28.68 in the prior trading day, Integra Lifesciences Holdings Corp (NASDAQ: IART) closed at $28.98, up 1.05%. In other words, the price has increased by $1.05 from its previous closing price. On the day, 1.61 million shares were traded. IART stock price reached its highest trading level at $29.375 during the session, while it also had its lowest trading level at $28.5.
Ratios:
Our goal is to gain a better understanding of IART by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.33 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 31.01. For the most recent quarter (mrq), Quick Ratio is recorded 2.18 and its Current Ratio is at 3.45. In the meantime, Its Debt-to-Equity ratio is 1.06 whereas as Long-Term Debt/Eq ratio is at 1.04.
On December 05, 2023, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $40 to $49.
On November 14, 2023, CL King started tracking the stock assigning a Buy rating and target price of $50.CL King initiated its Buy rating on November 14, 2023, with a $50 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 06 ’24 when DAVIS ROBERT T. JR. sold 8,348 shares for $36.59 per share. The transaction valued at 305,492 led to the insider holds 49,893 shares of the business.
Mosebrook Jeffrey sold 1,177 shares of IART for $52,329 on Aug 09 ’23. The SVP, Fin & PAO now owns 23,458 shares after completing the transaction at $44.46 per share. On Jun 01 ’23, another insider, De Witte Jan, who serves as the President & CEO of the company, bought 7,792 shares for $38.50 each. As a result, the insider paid 299,986 and bolstered with 12,798 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IART now has a Market Capitalization of 2277891840 and an Enterprise Value of 3617758208. As of this moment, Integra’s Price-to-Earnings (P/E) ratio for their current fiscal year is 34.36, and their Forward P/E ratio for the next fiscal year is 8.02. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.90. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.47 while its Price-to-Book (P/B) ratio in mrq is 1.43. Its current Enterprise Value per Revenue stands at 2.347 whereas that against EBITDA is 9.432.
Stock Price History:
Over the past 52 weeks, IART has reached a high of $59.10, while it has fallen to a 52-week low of $27.85. The 50-Day Moving Average of the stock is -21.51%, while the 200-Day Moving Average is calculated to be -27.40%.
Shares Statistics:
The stock has traded on average 699.41K shares per day over the past 3-months and 826210 shares per day over the last 10 days, according to various share statistics. A total of 78.17M shares are outstanding, with a floating share count of 66.12M. Insiders hold about 15.47% of the company’s shares, while institutions hold 85.04% stake in the company. Shares short for IART as of 1711584000 were 2093923 with a Short Ratio of 2.99, compared to 1709164800 on 2511912. Therefore, it implies a Short% of Shares Outstanding of 2093923 and a Short% of Float of 3.08.
Earnings Estimates
Integra Lifesciences Holdings Corp (IART) is currently under the scrutiny of Maplebear Inc. analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is $15.83, with high estimates of $25.32 and low estimates of $28.98.
